Skip to main content
Erschienen in: Critical Care 1/2015

Open Access 01.12.2015 | Letter

2015, big data in healthcare: for whom the bell tolls?

verfasst von: Sven Van Poucke, Michiel Thomeer, Admir Hadzic

Erschienen in: Critical Care | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Competing interests

SVP and MT declare that they have no competing interests. AH consulted and advised for Skypharma, GE, Sonosite, Codman & Shrutleff, Inc. (Johnson and Johnson), Cadence, Pacira Pharmaceuticals, Baxter and BBraun Medical. Research funding from Glaxo Smith-Kline Industries, Pacira, Baxter. AH receives royalty income from BBraun Medical.

Authors’ contributions

SVP, MT, and AH contributed equally in writing this letter. All authors read and approved the final manuscript.
The health care sector generates bountiful data around the clock, which can paradoxically complicate our quest for information, knowledge, and ‘wisdom’ [1]. It may be prudent that medical end-users consider seriously a fundamental change that would allow us to gain full value from the ‘big data’ that the health care section is generating [2]. Proponents of the big data revolution suggest that the value for physicians rests on the added information provided by big data analysis. Indeed, supplementary information could clarify areas for improvement, such as optimization of treatments, reduced adverse events and readmission rates, earlier identification of those patients whose health is worsening, and more efficient identification of populations in need. Recent cloud computing has even turned computing and software into commodity services, and such big data processing seems to be forging a technology revolution [3,4]. However, opponents of the big data revolution speculate that validation and impact analyses of big data in health care are still in their infancy, and approaches such as Google’s baseline study may thus not be effective in preventing disease, and possibly even lead to unnecessary, if not harmful, interventions [5].
The value of any kind of data is greatly enhanced when it exists in a form that allows for integration with other data [6]. One problem with large data sets in general is the risk for ‘GIGO’ - garbage in, garbage out - that requires very careful and thoughtful investigation to rule out the many errors of large-scale data capture before any of it can be used. Thus, an essential step for data integration is the annotation of multiple bodies of data using common controlled vocabularies or ‘ontologies’ that incorporate accurate representations of biological reality [7]. Data mining in health care is not new, and initiatives for data acquisition and analysis, storage and retrieval have all been presented before [8,9]. Yet, to our knowledge, subcommittees addressing ontology have not been established by any medical specialty.
As clinicians, we apply general principles of risk stratification and risk modification to individual patients based on our education and experience. The proliferation of biomedical research makes it difficult to keep abreast of current knowledge, so clinical decision support technologies that are based on data mining techniques are knocking at our doors. Although their implementation seems inevitable, the lack of standardization continues [9]. A dramatic paradigm shift toward controlled ontologies is needed in order to optimize the technologies that integrate big data into medical decision making and practice.

Acknowledgements

All authors (SVP, MT, AH) declare that this letter was written with no funding. No role was played by any funding body in the design, collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

SVP and MT declare that they have no competing interests. AH consulted and advised for Skypharma, GE, Sonosite, Codman & Shrutleff, Inc. (Johnson and Johnson), Cadence, Pacira Pharmaceuticals, Baxter and BBraun Medical. Research funding from Glaxo Smith-Kline Industries, Pacira, Baxter. AH receives royalty income from BBraun Medical.

Authors’ contributions

SVP, MT, and AH contributed equally in writing this letter. All authors read and approved the final manuscript.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Henry NL. Knowledge management: a new concern for public administration. Public Administration Rev. 1974;34:189–96.CrossRef Henry NL. Knowledge management: a new concern for public administration. Public Administration Rev. 1974;34:189–96.CrossRef
2.
Zurück zum Zitat Groves P, Kayyali B, Knott D, Van Kuiken S. The ‘ big data ’ revolution in healthcare. Accelerating value and innovation. McKinsey Global Institute: New York, NY; 2013. Groves P, Kayyali B, Knott D, Van Kuiken S. The ‘ big data ’ revolution in healthcare. Accelerating value and innovation. McKinsey Global Institute: New York, NY; 2013.
4.
Zurück zum Zitat Herland M, Khoshgoftaar TM, Wald R. A review of data mining using big data in health informatics. J Big Data. 2014;1:2.CrossRef Herland M, Khoshgoftaar TM, Wald R. A review of data mining using big data in health informatics. J Big Data. 2014;1:2.CrossRef
5.
Zurück zum Zitat Diamandis EP. The hundred person wellness project and Google’s baseline study: medical revolution or unnecessary and potentially harmful over-testing? BMC Med. 2015;3:5.CrossRef Diamandis EP. The hundred person wellness project and Google’s baseline study: medical revolution or unnecessary and potentially harmful over-testing? BMC Med. 2015;3:5.CrossRef
6.
Zurück zum Zitat Daghavan D. Big data: not really the same as level 1 data. Oncology (Williston Park). 2015;29:70, 72. Daghavan D. Big data: not really the same as level 1 data. Oncology (Williston Park). 2015;29:70, 72.
7.
Zurück zum Zitat Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol. 2007;25:1251–5.CrossRef Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol. 2007;25:1251–5.CrossRef
8.
Zurück zum Zitat Lee J, Scott DJ, Villarroel M, Clifford GD, Saeed M, Mark RG. Open-access MIMIC-II database for intensive care research. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:8315–8.PubMedCentral Lee J, Scott DJ, Villarroel M, Clifford GD, Saeed M, Mark RG. Open-access MIMIC-II database for intensive care research. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:8315–8.PubMedCentral
9.
Zurück zum Zitat Dejam A, Malley BE, Feng M, Cismondi F, Park S, Samani S. The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients. Crit Care. 2014;18:487.CrossRef Dejam A, Malley BE, Feng M, Cismondi F, Park S, Samani S. The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients. Crit Care. 2014;18:487.CrossRef
Metadaten
Titel
2015, big data in healthcare: for whom the bell tolls?
verfasst von
Sven Van Poucke
Michiel Thomeer
Admir Hadzic
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2015
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-015-0895-8

Weitere Artikel der Ausgabe 1/2015

Critical Care 1/2015 Zur Ausgabe

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.